201 related articles for article (PubMed ID: 22048168)
41. Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells.
Schoeman R; Beukes N; Frost C
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066359
[TBL] [Abstract][Full Text] [Related]
42. WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors.
Rock RB; Gekker G; Hu S; Sheng WS; Cabral GA; Martin BR; Peterson PK
J Neuroimmune Pharmacol; 2007 Jun; 2(2):178-83. PubMed ID: 18040842
[TBL] [Abstract][Full Text] [Related]
43. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
44. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
45. Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2.
Fonseca BM; Fernandes R; Almada M; Santos M; Carvalho F; Teixeira NA; Correia-da-Silva G
Toxicology; 2019 Feb; 413():40-47. PubMed ID: 30502353
[TBL] [Abstract][Full Text] [Related]
46. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
[TBL] [Abstract][Full Text] [Related]
47. CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.
Hu S; Sheng WS; Rock RB
PLoS One; 2013; 8(10):e77577. PubMed ID: 24147028
[TBL] [Abstract][Full Text] [Related]
48. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2.
Zhang G; Bi H; Gao J; Lu X; Zheng Y
Cell Biochem Funct; 2016 Jul; 34(5):351-8. PubMed ID: 27309350
[TBL] [Abstract][Full Text] [Related]
50. Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.
Li MH; Suchland KL; Ingram SL
J Neurosci; 2017 Jan; 37(3):626-636. PubMed ID: 28100744
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Scholl A; Ivanov I; Hinz B
Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
[TBL] [Abstract][Full Text] [Related]
52. Cannabinoid CB1 and CB2 receptors differentially modulate L- and T-type Ca
Qian WJ; Yin N; Gao F; Miao Y; Li Q; Li F; Sun XH; Yang XL; Wang Z
Neuropharmacology; 2017 Sep; 124():143-156. PubMed ID: 28431968
[TBL] [Abstract][Full Text] [Related]
53. [The synthetic cannabinoid analog WIN 55,212-2 potentiates the amplitudes of glycine-activated currents].
Iatsenko NM; Tsintsadze TSh; Lozova NO
Fiziol Zh (1994); 2007; 53(3):31-7. PubMed ID: 17725041
[TBL] [Abstract][Full Text] [Related]
54. Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1.
Martini L; Thompson D; Kharazia V; Whistler JL
Neuropsychopharmacology; 2010 May; 35(6):1363-73. PubMed ID: 20164830
[TBL] [Abstract][Full Text] [Related]
55. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
Ganon-Elazar E; Akirav I
Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
[TBL] [Abstract][Full Text] [Related]
56. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats.
Nasehi M; Sahebgharani M; Haeri-Rohani A; Zarrindast MR
Neurobiol Learn Mem; 2009 Oct; 92(3):391-9. PubMed ID: 19450698
[TBL] [Abstract][Full Text] [Related]
57. The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas.
Wasik AM; Christensson B; Sander B
Semin Cancer Biol; 2011 Nov; 21(5):313-21. PubMed ID: 22024769
[TBL] [Abstract][Full Text] [Related]
58. Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.
De Jesús ML; Hostalot C; Garibi JM; Sallés J; Meana JJ; Callado LF
Neurochem Int; 2010; 56(6-7):829-33. PubMed ID: 20307616
[TBL] [Abstract][Full Text] [Related]
59. Cannabinoid-induced chemotaxis in bovine corneal epithelial cells.
Murataeva N; Li S; Oehler O; Miller S; Dhopeshwarkar A; Hu SS; Bonanno JA; Bradshaw H; Mackie K; McHugh D; Straiker A
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3304-13. PubMed ID: 26024113
[TBL] [Abstract][Full Text] [Related]
60. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
